Alexandra Emilia Schlaak

2PUBLICATIONS
56CO-AUTHORS
Medical infection agents (incl. prions)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Oct 03, 2025
FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia.

Melissa Zwick, Bastian Zinkel, Corinna Spohr

|Apr 05, 2024
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study.

David J Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi

Pageof 1

Frequent Collaborators

2 joint publications

Bertram Bengsch

1 joint publications

David J Pinato

1 joint publications

Antonio D'Alessio

1 joint publications

Claudia Angela Maria Fulgenzi

1 joint publications

Ciro Celsa

1 joint publications

Saskia Killmer

1 joint publications

Jesus Miguens Blanco

1 joint publications

Caroline Ward

1 joint publications

Charalampos-Vlasios Stikas

1 joint publications

Mark R Openshaw

Frequent Collaborators

2 joint publications

Bertram Bengsch

1 joint publications

David J Pinato

1 joint publications

Antonio D'Alessio

1 joint publications

Claudia Angela Maria Fulgenzi

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

842
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on : Sep 20, 2020

5.6K
See more related videos

Top Related Videos

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

842
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on : Sep 20, 2020

5.6K
See more related videos